365bet娱乐

TAK-876 is a selective G protein-coupled receptor 40 (GPR40) agonist. TAK-876 is a novel oral medication that has been developed to improve the secretion of insulin in a glucose-dependent manner, which has the potential to improve the control of blood sugar levels without the risk of hypoglycemia.

Product Details:

Name: TAK875

Synonyms: 

CAS:1000413-72-8

2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydro-1-benzofuran-3-yl]acetic acid;

((3S)-6-({3-[4-(3-methanesulfonylpropoxy)-2,6-dimethylphenyl]phenyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl)acetic acid;

Fasiglifam;

3-Benzofuranacetic acid,6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-,(3S);

TAK-875;

Fasiglifam (INN);

CAS:1000413-72-8

EINECS:N/A

MF:C29H32O7S

MW:524.62500

Density:1.252

BP:739.1±60.0 °C(Predicted)

MP:N/A

FP:N/A

Purity: 97%+

Storage condition: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Stability:Stable under normal temperature and pressure

Acidity factor (pKa):4.36±0.10(Predicted)

Package: 5g, 25g, 100g, 500g, 1kg, 25kg

Hot Tags: tak875 cas:1000413-72-8, China, manufacturers, in stock, free sample, high quality, low price, CAS 13678 58 5, Ethyl Azidoacetate, 1 methylsulfanylbutan 2 one, CAS 75726 96 4, R NAPROXEN, 4S 5S 4 5 Bis diphenylphosphinomethyl 2 2 dimethyl 1 3 dioxolane